Skip to main content
Clinical Trials/CTRI/2023/12/060480
CTRI/2023/12/060480
Completed
Phase 3

EFFECT OF STANDARD FLUID THERAPY AND GOAL DIRECTED FLUID THERAPY ON EARLY POSTOPERATIVE OUTCOME IN PATIENTS UNDERGOING ELECTIVE COLORECTAL SURGERY A COMPARATIVE STUDY - NI

SUBHA SANKAR DAS0 sites162 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: C18- Malignant neoplasm of colonHealth Condition 2: C189- Malignant neoplasm of colon, unspecified
Sponsor
SUBHA SANKAR DAS
Enrollment
162
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 5, 2024
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
SUBHA SANKAR DAS

Eligibility Criteria

Inclusion Criteria

  • The study will be performed on adult patients, aged 18\-65 years, with NYHA class 1\-3 undergoing elective colorectal surgery under general anaesthesia, will be considered for the study. Other criteria that will be considered for inclusion are body weight: 55 kg \-140 kg and serum albumin \>2\.5 gm/dl. Patients who will give written informed consent to participate in the study.

Exclusion Criteria

  • The following patients will be excluded.
  • I.Patients with Cognitive limitation
  • II.Patients with Ejection fraction \<30%
  • III.Patients with active cardiac dysrhythmia (e.g., rate controlled atrial fibrillation)
  • IV.Patients with Pulmonary disease where expected to receive less than 8 ml/kg tidal volumes
  • V.Patients with Sleep apnoea
  • VI.Patients with Renal disease

Outcomes

Primary Outcomes

Not specified

Similar Trials